Comment on: Efficacy and Safety of Mycophenolate Mofetil versus Intravenous Pulse Cyclophosphamide as Induction Therapy in Proliferative Lupus Nephritis

被引：0
|
作者：
Ziaie, Shadi [1 ]
Moradi, Omid [2 ]
Saffaei, Ali [2 ]
机构：
[1] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Clin Pharm, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Clin Pharm, Student Res Comm, Tehran, Iran
来源：
IRANIAN JOURNAL OF KIDNEY DISEASES | 2019年 / 13卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：347 / 347
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Mycophenolate Mofetil Versus Intravenous Pulse Cyclophosphamide as Induction Therapy in Proliferative Lupus Nephritis
    Gadakchi, Leyla
    Hajialilo, Mehrzad
    Nakhjavani, Mohammad-Reza
    Azar, Sima Abedi
    Kolahi, Sousan
    Gojazadeh, Morteza
    Ebrahimi, Ali-asghar
    Mahdavi, Aida Malek
    Noshad, Hamid
    Khabbazi, Alireza
    [J]. IRANIAN JOURNAL OF KIDNEY DISEASES, 2018, 12 (05) : 288 - 292
  • [2] Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis
    Ong, LM
    Hooi, LS
    Lim, TO
    Goh, BL
    Ahmad, G
    Ghazalli, R
    Teo, SM
    Wong, HS
    Tan, SY
    Shaariah, W
    Tan, CC
    Morad, Z
    [J]. NEPHROLOGY, 2005, 10 (05) : 504 - 510
  • [3] RANDOMIZED CONTROLLED TRIAL OF PULSE INTRAVENOUS CYCLOPHOSPHAMIDE VERSUS MYCOPHENOLATE MOFETIL IN THE INDUCTION THERAPY OF PROLIFERATIVE LUPUS NEPHRITIS
    Ong, Loke Meng
    Hooi, Lai Seong
    Lim, Teck Onn
    Goh, Bak Leong
    Ahmad, Ghazali
    Ghazalli, Rozina
    Teo, Sue Mei
    Wong, Hin Seng
    Tan, Si Yen
    Shaariah, Wan
    Tan, Chwee Choon
    Morad, Zaki
    [J]. NEPHROLOGY, 2005, 10 : A121 - A121
  • [4] Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?
    Eid M. El-Shafey
    Said H. Abdou
    Mohamed M. Shareef
    [J]. Clinical and Experimental Nephrology, 2010, 14 : 214 - 221
  • [5] Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?
    El-Shafey, Eid M.
    Abdou, Said H.
    Shareef, Mohamed M.
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2010, 14 (03) : 214 - 221
  • [6] Induction Therapy for Pediatric Focal Proliferative Lupus Nephritis: Cyclophosphamide Versus Mycophenolate Mofetil
    Lau, Keith K.
    Ault, Bettina H.
    Jones, Deborah P.
    Butani, Lavjay
    [J]. JOURNAL OF PEDIATRIC HEALTH CARE, 2008, 22 (05) : 282 - 288
  • [7] Efficacy and safety of high-dose of mycophenolate mofetil compared with cyclophosphamide pulse therapy as induction therapy in Japanese patients with proliferative lupus nephritis
    Ohkubo, Naoaki
    Iwata, Shigeru
    Nakano, Kazuhisa
    Miyagawa, Ippei
    Hanami, Kentaro
    Fukuyo, Shunsuke
    Miyazaki, Yusuke
    Kawabe, Akio
    Nakayamada, Shingo
    Tanaka, Yoshiya
    [J]. MODERN RHEUMATOLOGY, 2022, 32 (06) : 1077 - 1085
  • [8] Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide
    Christian Burchardi
    Detlef Schlöndorff
    [J]. Nature Clinical Practice Nephrology, 2006, 2 : 314 - 315
  • [9] Mycophenolate mofetil versus intravenous cyclophosphamide for induction treatment of proliferative lupus nephritis in a Japanese population: a retrospective study
    Onishi, Akira
    Sugiyama, Daisuke
    Tsuji, Go
    Nakazawa, Takashi
    Kogata, Yoshinori
    Tsuda, Kosaku
    Naka, Ikuko
    Nishimura, Keisuke
    Misaki, Kenta
    Kurimoto, Chiyo
    Hayashi, Hiroki
    Kageyama, Goichi
    Saegusa, Jun
    Sugimoto, Takeshi
    Kawano, Seiji
    Kumagai, Shunichi
    Morinobu, Akio
    [J]. MODERN RHEUMATOLOGY, 2013, 23 (01) : 89 - 96
  • [10] Induction therapy for active lupus nephritis:: mycophenolate mofetil versus cyclophosphamide -: Commentary
    Burchardi, Christian
    Schloendorff, Detlef
    [J]. NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (06): : 314 - 315
12345